Flu vaccination rates among children and adults have significantly decreased, with only 55% of children and less than 45% of adults vaccinated in 2024. Factors contributing to this decline include political attacks on vaccines and limited access to health insurance for many children. AstraZeneca is addressing these issues with FluMist, the first at-home nasal flu vaccine that can be ordered online and delivered directly to home. This product includes instructions for safe administration, intending to make vaccination more accessible and convenient for families busy with daily life.
Flu vaccination rates dropped with 55% of children and less than 45% of adults vaccinated in 2024. This decline is influenced by political opposition and health insurance access issues.
AstraZeneca is launching FluMist, the first at-home nasal flu vaccine. It aims to simplify the vaccination process for families by removing common barriers.
Receiving FluMist involves ordering online and delivery to your home. Users must download the tiveTag app to confirm the vaccine's safe temperature storage.
To administer FluMist, refrigerate upon arrival, and follow guidelines to remove the cap and use the dose divider, ensuring a safe and easy process.
Collection
[
|
...
]